Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02065765 |
| Title | International Expanded Access Program to Provide Ramucirumab for the Treatment of Metastatic Gastric Cancer |
| Recruitment | No longer available |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Eli Lilly and Company |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | NLD | GRC | DEU | AUT |